COCP vs VNO · rev $105.0K vs rev $921.3M
Cocrystal Pharma Inc (COCP) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
COCP currently screens at market cap $13.3M. VNO currently screens at market cap $0.
Not investment advice. Open the COCP and VNO stock pages for the full models.
Not investment advice.